Suppr超能文献

腺苷用于院前阵发性室上性心动过速的治疗。

Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.

作者信息

Gausche M, Persse D E, Sugarman T, Shea S R, Palmer G L, Lewis R J, Brueske P J, Mahadevan S, Melio F R, Kuwate J H

机构信息

UCLA School of Medicine, Torrance.

出版信息

Ann Emerg Med. 1994 Aug;24(2):183-9. doi: 10.1016/s0196-0644(94)70128-8.

Abstract

STUDY OBJECTIVE

To determine the efficacy and feasibility of adenosine for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the prehospital setting.

DESIGN

Prospective case series.

SETTING

Large, urban, advanced life support emergency medical services system.

PARTICIPANTS

One hundred twenty-nine adult patients with PSVT, as identified by paramedic personnel. Pregnant patients and those taking carbamazepine or dipyridamole were excluded.

INTERVENTIONS

Dose of 12 mg adenosine by rapid i.v. push followed by a 5-mL saline flush and a repeat dose of 12 mg adenosine i.v. push if the patient's rhythm remained unchanged.

MEASUREMENTS AND MAIN RESULTS

Six-second lead II rhythm strips and vital signs were documented before and 2 minutes after the administration of adenosine. Demographic information, past medical history, medications, number of adenosine doses given, and complications were recorded by the paramedic on a case-report form. One hundred six of 129 (82%) of the case-report forms included the rhythm strips from before and after adenosine administration. Actual initial rhythms were determined by a consensus panel. The initial rhythms were PSVT in 79% (84 of 106) of patients, atrial fibrillation in 12% (13 of 106), sinus tachycardia in 5% (five of 106), atrial flutter in 2% (two of 106), and ventricular tachycardia in 2% (two of 106). Eighty-five percent (71 of 84) of patients in PSVT were successfully converted to sinus rhythms; four (5.6%) of these patients required a second 12-mg dose. One patient in atrial fibrillation spontaneously converted to normal sinus rhythm and one patient in ventricular tachycardia converted after adenosine. All other patients not initially in PSVT remained in their initial rhythm. Complications occurred in 12 of 129 patients and included chest pain (five), flushing (three), shortness of breath (two), nausea (one), anxiety (one), dizziness (one), headache (one), and seizure (one). All complications were transient and required no treatment. Prior history of PSVT was the only variable associated with a higher rate of conversion (P = .029).

CONCLUSION

Paramedics are able to accurately identify PSVT using a single lead. Adenosine is safe and effective treatment for PSVT in the prehospital setting. This series is the largest prehospital study of adenosine use to date.

摘要

研究目的

确定腺苷在院前环境中治疗阵发性室上性心动过速(PSVT)的疗效和可行性。

设计

前瞻性病例系列研究。

地点

大型城市高级生命支持急救医疗服务系统。

参与者

经护理人员确诊的129例成年PSVT患者。排除孕妇以及正在服用卡马西平或双嘧达莫的患者。

干预措施

快速静脉推注12mg腺苷,随后用5ml生理盐水冲管;若患者心律未改变,则重复静脉推注12mg腺苷。

测量指标及主要结果

在给予腺苷前及给药后2分钟记录II导联6秒心律条图和生命体征。护理人员在病例报告表上记录人口统计学信息、既往病史、用药情况、腺苷给药剂量及并发症。129份病例报告表中有106份(82%)包含腺苷给药前后的心律条图。实际初始心律由一个共识小组确定。初始心律为PSVT的患者占79%(106例中的84例),房颤占12%(106例中的13例),窦性心动过速占5%(106例中的5例),房扑占2%(106例中的2例),室性心动过速占2%(106例中的2例)。PSVT患者中有85%(84例中的71例)成功转为窦性心律;其中4例(5.6%)患者需要第二次静脉推注12mg腺苷。1例房颤患者自发转为正常窦性心律,1例室性心动过速患者在使用腺苷后转为窦性心律。所有最初非PSVT的患者维持初始心律。129例患者中有12例出现并发症,包括胸痛(5例)、潮红(3例)、呼吸急促(2例)、恶心(1例)、焦虑(1例)、头晕(1例)、头痛(1例)和癫痫发作(1例)。所有并发症均为短暂性,无需治疗。既往PSVT病史是与较高转复率相关的唯一变量(P = 0.029)。

结论

护理人员能够使用单导联准确识别PSVT。腺苷在院前环境中是治疗PSVT的安全有效药物。本系列研究是迄今为止关于腺苷院前应用的最大规模研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验